The main indications for rFVIIa are perioperative prophylaxis and treatment of haemorrhage in patients with haemophilia A or B, who have developed inhibitors; in patients with acquired haemophilia; in patients with congenital factor VII deficiency; and in patients with Glanzmann’s thrombasthenia, who cannot be treated by transfusion of platelets.